These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3913530)

  • 21. Local controlled drug delivery to the brain: mathematical modeling of the underlying mass transport mechanisms.
    Siepmann J; Siepmann F; Florence AT
    Int J Pharm; 2006 May; 314(2):101-19. PubMed ID: 16647231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Liposomal drug delivery systems--clinical applications.
    Goyal P; Goyal K; Vijaya Kumar SG; Singh A; Katare OP; Mishra DN
    Acta Pharm; 2005 Mar; 55(1):1-25. PubMed ID: 15907221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biodegradable polymers in controlled drug delivery.
    Heller J
    Crit Rev Ther Drug Carrier Syst; 1984; 1(1):39-90. PubMed ID: 6400195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies.
    Gabizon A; Horowitz AT; Goren D; Tzemach D; Mandelbaum-Shavit F; Qazen MM; Zalipsky S
    Bioconjug Chem; 1999; 10(2):289-98. PubMed ID: 10077479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo.
    Leamon CP; Cooper SR; Hardee GE
    Bioconjug Chem; 2003; 14(4):738-47. PubMed ID: 12862426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recent development of targeted drug delivery system].
    Zhou PJ; Deng SQ; Gong QF
    Yao Xue Xue Bao; 2010 Mar; 45(3):300-6. PubMed ID: 21351504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug permeability across a phospholipid vesicle based barrier: a novel approach for studying passive diffusion.
    Flaten GE; Dhanikula AB; Luthman K; Brandl M
    Eur J Pharm Sci; 2006 Jan; 27(1):80-90. PubMed ID: 16246536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protease-sensitive, polymer-caged liposomes: a method for making highly targeted liposomes using triggered release.
    Basel MT; Shrestha TB; Troyer DL; Bossmann SH
    ACS Nano; 2011 Mar; 5(3):2162-75. PubMed ID: 21314184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Problems in creating insulin preparations with increased stability against proteolysis].
    Valuev LI; Valuev IL; Sytov GA
    Prikl Biokhim Mikrobiol; 1996; 32(4):371-81. PubMed ID: 8984475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fabrication of nanoparticles within polymeric pores for controlled release of drug.
    Asif M; Arayne MS; Sultana N; Hussain F
    Pak J Pharm Sci; 2006 Jan; 19(1):73-84. PubMed ID: 16632458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
    Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
    Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preliminary observations on the absorption of liposome-encapsulated drug by the intestinal lymphatics.
    Ueda CT; Nickols JG; Schmelter RF
    Res Commun Chem Pathol Pharmacol; 1981 Jun; 32(3):487-98. PubMed ID: 7268193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A synthetic peptide mediated active targeting of cisplatin liposomes to Tie2 expressing cells.
    Mai J; Song S; Rui M; Liu D; Ding Q; Peng J; Xu Y
    J Control Release; 2009 Nov; 139(3):174-81. PubMed ID: 19576253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolonged release biodegradable vesicular carriers for rifampicin--formulation and kinetics of release.
    Kamath MP; Shenoy BD; Tiwari SB; Karki R; Udupa N; Kotian M
    Indian J Exp Biol; 2000 Feb; 38(2):113-8. PubMed ID: 11218826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biological effects of soluble synthetic polymers as drug carriers.
    Duncan R
    Crit Rev Ther Drug Carrier Syst; 1985; 1(4):281-310. PubMed ID: 3913527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymer blends for controlled release coatings.
    Siepmann F; Siepmann J; Walther M; MacRae RJ; Bodmeier R
    J Control Release; 2008 Jan; 125(1):1-15. PubMed ID: 18022722
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual-targeting topotecan liposomes modified with tamoxifen and wheat germ agglutinin significantly improve drug transport across the blood-brain barrier and survival of brain tumor-bearing animals.
    Du J; Lu WL; Ying X; Liu Y; Du P; Tian W; Men Y; Guo J; Zhang Y; Li RJ; Zhou J; Lou JN; Wang JC; Zhang X; Zhang Q
    Mol Pharm; 2009; 6(3):905-17. PubMed ID: 19344115
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnetic field-induced drug permeability in liposome vesicles.
    Liburdy RP; Tenforde TS; Magin RL
    Radiat Res; 1986 Oct; 108(1):102-11. PubMed ID: 3774963
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liposomes for oral administration of drugs.
    Woodley JF
    Crit Rev Ther Drug Carrier Syst; 1985; 2(1):1-18. PubMed ID: 3913528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trigger release liposome systems: local and remote controlled delivery?
    Bibi S; Lattmann E; Mohammed AR; Perrie Y
    J Microencapsul; 2012; 29(3):262-76. PubMed ID: 22208705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.